clinical hold

Stop sign

Biotech

PepGen hit with partial hold, analyst blames 'understaffed FDA'

The FDA put a partial hold on PepGen’s phase 2 muscle wasting trial after reviewing preclinical data, continuing the stop-start advance of the asset.

Nick Paul Taylor Mar 5, 2026 5:45am

Small bird flying out of a cage

FDA fully releases clinical hold on Intellia CRISPR trials

Mar 2, 2026 10:55am

pause halt pause button

FDA freezes enrollment in MacroGenics cancer trial after death

Feb 24, 2026 2:00pm

Image of a neon sign with the word no lit up next to an unlit yes

FDA rejects Regenxbio's Hunter syndrome gene therapy

Feb 9, 2026 4:05pm

Make a delay and accumulation of outstanding tasks Full stop

Brain tumor prompts FDA hold for 2 Regenxbio gene therapies

Jan 28, 2026 9:42am

gold arrow pointing upward forward

FDA frees Intellia of 1 clinical hold for CRISPR therapy

Jan 27, 2026 10:54am